Table 3.
ART treatment and other medication-related characteristics of patients.
| Characteristics | Frequency | Percentage | |
|
| |||
| ART eligibility criteria | CD4 < 350 and WHO stage IV | 16 | 6.8 |
| WHO stage II and III | 26 | 10.9 | |
| Without criteria | 195 | 82.3 | |
| OI prophylaxis | Yes | 225 | 94.9 |
| No | 12 | — | |
| ART side effects during follow-up | Yes | 130 | 54.8 |
| No | 107 | 45.2 | |
| Regimen change during follow-up | Yes | 103 | 43.3 |
| No | 134 | 56.7 | |